Scienture Holdings (SCNX) Payables (2013 - 2026)
Scienture Holdings' (SCNX) quarterly Payables came in at $2.0 million in Q2 2026, down 60.38% year-over-year from $5.1 million in Q2 2025, and up 44.87% quarter-over-quarter from $1.4 million in Q1 2026.
Analysis
Scienture Holdings (SCNX) Payables (2013 - 2026) Analysis & Trends
Scienture Holdings has disclosed Payables across 14 years of filings, most recently posting $2.0 million for Q2 2026.
- In Q2 2026, Payables fell 60.38% year-over-year to $2.0 million; the TTM figure through Jun 2026 stood at $2.0 million (down 60.38% YoY), while the FY2025 annual figure was $1.4 million, down 72.16% from the prior year.
- Payables came in at $2.0 million for Q2 2026 at Scienture Holdings, up from $1.4 million in the prior quarter.
- In the past five years, Payables ranged from a high of $6.6 million in Q3 2023 to a low of $726266.0 in Q2 2024.
- Average Payables over 5 years is $2.5 million, with a median of $1.5 million recorded in 2023.
- Year-over-year, Payables sank 74.25% in 2024 and surged 607.24% in 2025.
- Over 5 years, Payables stood at $1.1 million in 2022, then surged by 31.03% to $1.5 million in 2023, then surged by 254.34% to $5.2 million in 2024, then tumbled by 72.16% to $1.4 million in 2025, then surged by 41.01% to $2.0 million in 2026.
- Per Business Quant data, the three most recent Payables figures were $2.0 million in Q2 2026, $1.4 million in Q1 2026, and $1.4 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | 2.72 Bn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | 1.73 Bn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | 449.39 Mn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | 721.21 Mn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 593.00 Mn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 73.83 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | 171.84 Mn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 251.37 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | 5.52 Mn |
| 10 | Scienture Holdings | 15.19 Mn | 15.19 Mn | 335,779.00 | 2.04 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.04 Mn |
| Mar 31, 2026 | 1.40 Mn |
| Dec 31, 2025 | 1.44 Mn |
| Jun 30, 2025 | 5.14 Mn |
| Mar 31, 2025 | 5.18 Mn |
| Dec 31, 2024 | 5.18 Mn |
| Jun 30, 2024 | 726,266.00 |
| Mar 31, 2024 | 953,098.00 |
| Dec 31, 2023 | 1.46 Mn |
| Sep 30, 2023 | 6.56 Mn |
| Jun 30, 2023 | 2.82 Mn |
| Dec 31, 2022 | 1.12 Mn |
| Sep 30, 2022 | 1.24 Mn |
| Jun 30, 2022 | 1.70 Mn |
| Mar 31, 2022 | 1.08 Mn |
| Dec 31, 2021 | 477,028.00 |
| Sep 30, 2021 | 275,220.00 |
| Jun 30, 2021 | 393,374.00 |
| Mar 31, 2021 | 591,471.00 |
| Dec 31, 2020 | 481,829.00 |